Mill Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.5M Buy
25,422
+23,594
+1,291% +$24.1M 2.04% 15
2026
Q1
$1.68M Hold
1,828
0.13% 66
2025
Q4
$1.96M Buy
1,828
+26
+1% +$24.9K 0.14% 60
2025
Q3
$1.37M Hold
1,802
0.1% 67
2025
Q2
$1.4M Sell
1,802
-1
-0.1% -$777 0.11% 67
2025
Q1
$1.49M Hold
1,803
0.12% 63
2024
Q4
$1.39M Hold
1,803
0.11% 69
2024
Q3
$1.6M Hold
1,803
0.12% 61
2024
Q2
$1.63M Hold
1,803
0.13% 61
2024
Q1
$1.4M Hold
1,803
0.12% 69
2023
Q4
$1.05M Hold
1,803
0.09% 77
2023
Q3
$968K Hold
1,803
0.09% 76
2023
Q2
$846K Buy
1,803
+134
+8% +$56.2K 0.08% 83
2023
Q1
$573K Buy
1,669
+11
+0.7% +$3.71K 0.06% 93
2022
Q4
$607K Hold
1,658
0.07% 86
2022
Q3
$536K Buy
1,658
+35
+2% +$11.1K 0.06% 87
2022
Q2
$526K Hold
1,623
0.06% 90
2022
Q1
$465K Buy
1,623
+123
+8% +$31.7K 0.04% 101
2021
Q4
$414K Buy
+1,500
New +$380K 0.04% 93

Other funds holding LLY

Mill Capital Management's LLY Position: Q2 2026 in Review

Mill Capital Management increased its Eli Lilly (LLY) stake by 1,291% in Q2 2026, buying an estimated $24.1M and bringing the position to 25,422 shares worth $30.5M. The position accounts for 2.04% of the portfolio, ranked #15.

Mill Capital Management first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Mill Capital Management held 25,422 shares of Eli Lilly worth $30.5M as of Q2 2026.
  • Mill Capital Management bought 23,594 Eli Lilly shares in Q2 2026, an estimated $24.1M.
  • Eli Lilly made up 2.04% of Mill Capital Management's portfolio in Q2 2026, its #15 holding.
  • Mill Capital Management first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Mill Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.